Eyeluminaries

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Bill Carpou, CEO of Octane, to discuss his transition to executive chairman of the organization.

· Tell us about your background. 2:24

· How has Octane changed under your leadership? What does the future hold? 4:01

· What does Octane do? 8:57

· What will be different, and what will remain the same? 12:07

· What are the differences between ophthalmology/optometry and other specialties? 15:20

· What trends are you seeing in eye care? 18:08

· What is causing the slowdown of cataract procedures? 20:21

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn. To find out more about Octane, click here.

Disclosures: Carpou reports being CEO of Octane. Hovanesian reports consulting widely in the ophthalmic field and being a strategic medical advisor for Tenpoint Therapeutics. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Lab, Bain Capital, CVC Capital Partners and Zeiss; being executive chairman of Neurotech, Preceyes BV and TearLab; and sitting on the board of Centricity Vision, Crystilex, LensGen and Visus.

In this last episode from ASCRS 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Perry J. Sternberg of Sydnexis, Nancy Beesley, and Jean-Pierre Hubschman, MD, of Horizon Surgical Systems, to discuss myopia in children, cataract surgery assisted by AI and robotics, and more.

· Welcome Perry J. Sternberg and Nancy Beesley. 0:44

· How and why is SYD-101 different from atropine? 3:20

· What happened with the FDA approval? 8:24

· Tell us about the study. 10:57

· Welcome Jean-Pierre Hubschman, MD. 20:32

· Transitioning from retina to cataracts. 21:02

· How do you address concerns about AI replacing surgeons? 24:19

· Transitioning from physician to CEO. 28:46

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Warren Foust, the newest CEO and president of STAAR Surgical. They discuss changing careers, what it's like to find yourself in a leadership position and more.

· Introducing Warren Foust 0:44

· What advice would you give others about becoming a leader in ophthalmology? 7:13

· What did you learn throughout this process of change? 10:00

· What plans do you have for the future? 12:46

· How do you define innovation? 14:52

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode, live from SightLine 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Ben Bergo and Carol Kearney of Tenpoint Therapeutics.

They discuss the approval of Yuvezzi (carbachol 2.75% and brimonidine tartrate 0.1% ophthalmic solution) for presbyopia as well as what it takes to launch a new product in a competitive market.

· The beginning of Yuvezzi. 2:11

· How do you differentiate yourself from other products in the market? 7:34

· The fear of retinal detachment. 10:55

· Advice for young entrepreneurs. 13:31

· The decision to use brimonidine tartrate. 16:37

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In the last episode from this year's Live from Hawaiian Eye series, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down together to discuss the podcast's annual drug name awards.

· Vizz or the Mazzo "rizz." 02:37

· Qlosi gets the "cutesy" award. 04:01

· Tryptyr. 05:35

· Encelto. 06:57

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this special edition episode of Eyeluminaries, Jim Mazzo is live from Hawaiian Eye 2026 with special guest Cathleen McCabe, MD, host of Healio's Mend the Gap. They discuss what shaped their careers and how to be good mentors.

· Cathleen McCabe, MD 01:17

· An important career shift. 01:48

· "Grab every minute you can." 11:01

· Mentors and mentees. 13:55

Be sure to listen to the second of this conversation on Mend the Gap.

Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn. For more from Cathleen McCabe, MD, follow her @CathyEye on Instagram and on X.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026 with guests Elizabeth Yeu, MD, and Allen C. Ho, MD. They discuss cataract and retina surgery, managing work-life balance and more.

· Welcome to Eyeluminaries. 00:01

· Elizabeth Yeu, MD, 00:11

· How do you see Implantable Collamer Lens (ICL, STAAR Surgical) surgery expanding? 01:23

· How long have you been with Tarsus Pharmaceuticals? 05:00

· How do you have work-life balance? 08:21

· Allen C. Ho, MD 11:38

· What got you into retina? 12:55

· How has the evolution of retina surgery changed your practice? 14:55

· Tell us about your role at Eyecelerator. 17:00

· How do you manage your work-life balance? 18:39

· Thank you! 20:19

Elizabeth Yeu, MD, is an ophthalmologist and cornea and cataract surgeon. She is the chief medical officer of Tarsus Pharmaceuticals as well as past president of the American Society of Cataract and Refractive Surgery.

Allen C. Ho, MD, is a retina surgeon at Wills Eye Hospital, past president of the Retina Society and Eyecelerator retina program chair.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guests Baruch D. Kuppermann, MD, PhD and L. Jay Katz, MD. They discuss everything from their unique career journeys to the current treatments and procedures in eye care.

• Welcome to Eyeluminaries 00:10
• Recap of AAO episode 00:34
• Intro of Baruch D. Kuppermann, MD, PhD 01:28
• What made you enter retina and how has your career evolved? 03:02
• The Gavin Herbert Eye Institute 06:02
• What are your other interests? 12:09
• Nonprofit work and the Armenian EyeCare Project 13:07
• Intro of L. Jay Katz, MD 17:14
• How did you get into glaucoma? 18:03
• How are things going to evolve in treatment and procedures? 20:28
• What was the driving force behind leaving academia and working with Glaukos? 25:01
• Tell us a favorite Tom Burns story! 26:44
• Thank you! 29:50

Baruch D. Kuppermann, MD, PhD, is the Roger F. Steinert Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine.

L. Jay Katz, MD, is the chief medical officer at Glaukos.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.

In this special episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guest Peter N. Slack, president and CEO of the Wyanoke Group, who was honored with the annual Lindstrom Leadership Award and Lecture .

• Welcome to Eyeluminaries 00:42
• Hawaiian Eye 2026 – Peter Slack receives the Lindstrom Leadership Award 01:08
• Intro of Peter Slack 02:42
• What is the history of OSN and your involvement of the company? 04:09
• The philosophy of the editorial board 06:41
• Lindstrom Leadership Award/ Longevity of employees 08:43
• Healio meetings and lifelong friends 10:58
• Healio meetings and golf 12:40
• Sunshine Eye 14:18
• Thank you, Peter Slack and congratulations! 16:29
• Check out Healio AI 17:02
• Thank you! 18:00

Peter N. Slack, is the president and CEO of the Wyanoke Group.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.

In the second installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guest Thomas Burns.

• Welcome to the Eyeluminaries podcast 00:01
• Quick recap of Part 1 00:08
• Intro of Thomas Burns 00:30
• How do we foresee the adoption of IDose? 02:02
• Where do you see the field of keratoconus going? 04:36
• What advice do you have for young people just starting out? 08:36
• Who is a mentor for you? 11:06
• Do you have a good Jim Mazzo story? 15:38
• Thank you, Tom Burns 16:44
• Thank you! 17:11

Thomas Burns is the chairman and CEO of Glaukos.

We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.